Trulieve CannabisTRLV -0.35%63 Pretax Margin % is 8.79% as of Mar. 2026, which is 34% below its 10-year median of 13.33. GuruFocus rates TRLV with a GF Score™ of 63/100 and a GF Value™ of $6.03 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 955 Drug Manufacturers companies, Trulieve Cannabis ranks better than 53.19% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Trulieve Cannabis Pretax Margin % Related Terms
Trulieve Cannabis Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Trulieve Cannabis's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trulieve Cannabis (TRLV) has a Pretax Margin % of 8.79% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Trulieve Cannabis and its competitors. This is 34% below median its historical median of 13.33. According to the industry distribution chart, Trulieve Cannabis ranks #447 out of 955 companies in the Drug Manufacturers industry, placing it in the top 46.8%.
Is Trulieve Cannabis' Pretax Margin % too high?
Trulieve Cannabis' current Pretax Margin % of 8.79% is 34% below median its 10-year median of 13.33. The Drug Manufacturers industry median Pretax Margin % is 7.28. Trulieve Cannabis' value of 8.79% is 20.7% above this industry median. Based on the distribution chart, Trulieve Cannabis ranks #447 out of 955 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Trulieve Cannabis has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #447 out of 955 companies for Pretax Margin %. This puts Trulieve Cannabis in the upper half of its industry. The industry median Pretax Margin % is 7.28. Trulieve Cannabis' value of 8.79% is 20.7% above this benchmark. While the company's 10-year median is 13.33 vs. the industry median of 7.28, Trulieve Cannabis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trulieve Cannabis's current Pretax Margin % of 8.79% is 20.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Trulieve Cannabis and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trulieve Cannabis's current Pretax Margin % is 8.79%, which is 34% below median its own 10-year median of 13.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (TRLV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.03, compared to a current price of $8.50 — trading 41% above its estimated fair value. The current Pretax Margin % is 8.79%, which is 34% below median its 10-year median of 13.33 and 20.7% above the Drug Manufacturers industry median of 7.28. Trulieve Cannabis' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Trulieve Cannabis (TRLV), the current Pretax Margin % is 8.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (TRLV) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of $8.50 is trading 41% above its estimated GF Value™ of $6.03.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for TRLV:
Pretax Margin %: 8.79% (34% below median its 10-year median of 13.33)
GF Value™: $6.03 vs. price of $8.50 (41% above fair value)
Industry Position: 20.7% above the Drug Manufacturers median (#447 of 955)
No single metric tells the full story. See the TRLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
63GF Score
Get the complete analysis for TRLV
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRLV has been successfully added to your 
